학술논문
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5
Document Type
Article
Author
Smith, John W., II; Buyse, Marc E.; Rastogi, Priya; Geyer, Charles E., Jr.; Jacobs, Samuel A.; Patocskai, Erica J.; Robidoux, André; Conlin, Alison K.; Ansari, Bilal; Keogh, George P.; Stella, Philip J.; Gross, Howard M.; Lord, Raymond S.; Polikoff, Jonathan A.; Mauquoi, Celine; Mamounas, Eleftherios P.; Swain, Sandra M.; Wolmark, Norman
Source
In Clinical Breast Cancer February 2017 17(1):48-54
Subject
Language
ISSN
1526-8209